Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2
The Omicron strains of SARS-CoV-2 pose a significant challenge to the development of effective antibody-based treatments as immune evasion has compromised most available immune therapeutics. Therefore, in the ‘arms race’ with the virus, there is a continuing need to identify new biologics for the pr...
Main Authors: | Cornish, K, Huo, J, Jones, L, Sharma, P, Thrush, JW, Abdelkarim, S, Kipar, A, Ramadurai, S, Weckener, M, Mikolajek, H, Liu, S, Buckle, I, Bentley, E, Kirby, A, Han, X, Laidlaw, SM, Hill, M, Eyssen, L, Norman, C, Le Bas, A, Clarke, J, James, W, Stewart, JP, Carroll, M, Naismith, JH, Owens, RJ |
---|---|
Format: | Journal article |
Language: | English |
Published: |
The Royal Society
2024
|
Similar Items
-
From llama to nanobody: a streamlined workflow for the generation of functionalised VHHs
by: Eyssen, LEA, et al.
Published: (2024) -
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
by: Huo, J, et al.
Published: (2021) -
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
by: Huo, J, et al.
Published: (2020) -
Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2
by: Qilong Tang, et al.
Published: (2021-11-01) -
A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)
by: Lu Y, et al.
Published: (2023-01-01)